Invention Grant
- Patent Title: Selective NR2B antagonists
- Patent Title (中): 选择性NR2B拮抗剂
-
Application No.: US13627130Application Date: 2012-09-26
-
Publication No.: US08722670B2Publication Date: 2014-05-13
- Inventor: Dalton King , Richard E. Olson , John E. Macor , Imadul Islam , Srinivasan Thangathirupathy , Jayakumar Sankara Warrier
- Applicant: Bristol-Myers Squibb Company
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent James Epperson
- Main IPC: C07D413/14
- IPC: C07D413/14 ; C07D487/04 ; A61K31/4709 ; A61K31/4245
Abstract:
The disclosure generally relates to compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds are ligands, antagonists of the NR2B receptor and may be useful for the treatment of various disorders of the central nervous system.
Public/Granted literature
- US20130085138A1 Selective NR2B Antagonists Public/Granted day:2013-04-04
Information query
